Michael York Insider Profile
4 Followers
Michael York, former VP & Corp. Dev at Phasebio Pharmaceuticals, holds 103.50K shares in Metacrine (Ticker: MTCR), holds 7.06K shares in Phasebio Pharmaceuticals (Ticker: PHASQ). Most recently, Michael York Sold ― shares of Metacrine on Jan 27, 2023 for an estimated value of $43.89K.
Michael York's Trading History
| MTCRMetacrine | Jan 27, 2023 | ― | Informative Sell | 43.89K | $60.13K | |
| PHASQPhasebio Pharmaceuticals | May 24, 2021 | ― | Uninformative Buy | 8.11K | $169.42 |
You May Also Like
Michael York insider profile FAQ
What stocks does Michael York hold?
Michael York holds: PHASQ, MTCR stocks.
What was Michael York’s latest transaction?
Michael York’s latest transaction was an Informative Sell of $43.89K.
What was Michael York's most profitable transaction?
Michael York’s most profitable transaction was an Informative Buy of PHASQ stock on December 11, 2018. The return on the trade was -15.20%.
What is Michael York's role in Phasebio Pharmaceuticals?
Michael York's role in Phasebio Pharmaceuticals is VP & Corp. Dev.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
